Literature DB >> 17494082

Generation of infectious molecular clones of simian immunodeficiency virus from fecal consensus sequences of wild chimpanzees.

Jun Takehisa1, Matthias H Kraus, Julie M Decker, Yingying Li, Brandon F Keele, Fréderic Bibollet-Ruche, Kenneth P Zammit, Zhiping Weng, Mario L Santiago, Shadrack Kamenya, Michael L Wilson, Anne E Pusey, Elizabeth Bailes, Paul M Sharp, George M Shaw, Beatrice H Hahn.   

Abstract

Studies of simian immunodeficiency viruses (SIVs) in their endangered primate hosts are of obvious medical and public health importance, but technically challenging. Although SIV-specific antibodies and nucleic acids have been detected in primate fecal samples, recovery of replication-competent virus from such samples has not been achieved. Here, we report the construction of infectious molecular clones of SIVcpz from fecal viral consensus sequences. Subgenomic fragments comprising a complete provirus were amplified from fecal RNA of three wild-living chimpanzees and sequenced directly. One set of amplicons was concatenated using overlap extension PCR. The resulting clone (TAN1.24) contained intact genes and regulatory regions but was replication defective. It also differed from the fecal consensus sequence by 76 nucleotides. Stepwise elimination of all missense mutations generated several constructs with restored replication potential. The clone that yielded the most infectious virus (TAN1.910) was identical to the consensus sequence in both protein and long terminal repeat sequences. Two additional SIVcpz clones were constructed by direct synthesis of fecal consensus sequences. One of these (TAN3.1) yielded fully infectious virus, while the second one (TAN2.69) required modification at one ambiguous site in the viral pol gene for biological activity. All three reconstructed proviruses produced infectious virions that replicated in human and chimpanzee CD4(+) T cells, were CCR5 tropic, and resembled primary human immunodeficiency virus type 1 isolates in their neutralization phenotype. These results provide the first direct evidence that naturally occurring SIVcpz strains already have many of the biological properties required for persistent infection of humans, including CD4 and CCR5 dependence and neutralization resistance. Moreover, they outline a new strategy for obtaining medically important "SIV isolates" that have thus far eluded investigation. Such isolates are needed to identify viral determinants that contribute to cross-species transmission and host adaptation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17494082      PMCID: PMC1933379          DOI: 10.1128/JVI.00551-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  SIVcpz in wild chimpanzees.

Authors:  Mario L Santiago; Cynthia M Rodenburg; Shadrack Kamenya; Frederic Bibollet-Ruche; Feng Gao; Elizabeth Bailes; Sreelatha Meleth; Seng-Jaw Soong; J Michael Kilby; Zina Moldoveanu; Babette Fahey; Martin N Muller; Ahidjo Ayouba; Eric Nerrienet; Harold M McClure; Jonathan L Heeney; Anne E Pusey; D Anthony Collins; Christophe Boesch; Richard W Wrangham; Jane Goodall; Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  Science       Date:  2002-01-18       Impact factor: 47.728

2.  MRBAYES: Bayesian inference of phylogenetic trees.

Authors:  J P Huelsenbeck; F Ronquist
Journal:  Bioinformatics       Date:  2001-08       Impact factor: 6.937

3.  Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.

Authors:  C A Derdeyn; J M Decker; J N Sfakianos; X Wu; W A O'Brien; L Ratner; J C Kappes; G M Shaw; E Hunter
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template.

Authors:  Jeronimo Cello; Aniko V Paul; Eckard Wimmer
Journal:  Science       Date:  2002-07-11       Impact factor: 47.728

5.  env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area.

Authors:  S Corbet; M C Müller-Trutwin; P Versmisse; S Delarue; A Ayouba; J Lewis; S Brunak; P Martin; F Brun-Vezinet; F Simon; F Barre-Sinoussi; P Mauclere
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

6.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

7.  Amplification of a complete simian immunodeficiency virus genome from fecal RNA of a wild chimpanzee.

Authors:  Mario L Santiago; Frederic Bibollet-Ruche; Elizabeth Bailes; Shadrack Kamenya; Martin N Muller; Magdalena Lukasik; Anne E Pusey; D Anthony Collins; Richard W Wrangham; Jane Goodall; George M Shaw; Paul M Sharp; Beatrice H Hahn
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  Foci of endemic simian immunodeficiency virus infection in wild-living eastern chimpanzees (Pan troglodytes schweinfurthii).

Authors:  Mario L Santiago; Magdalena Lukasik; Shadrack Kamenya; Yingying Li; Frederic Bibollet-Ruche; Elizabeth Bailes; Martin N Muller; Melissa Emery; David A Goldenberg; Jeremiah S Lwanga; Ahidjo Ayouba; Eric Nerrienet; Harold M McClure; Jonathan L Heeney; David P Watts; Anne E Pusey; D Anthony Collins; Richard W Wrangham; Jane Goodall; John F Y Brookfield; Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  HIV-1 group O infection in Cameroon, 1986 to 1998.

Authors:  A Ayouba; P Mauclère; P M Martin; P Cunin; J Mfoupouendoun; B Njinku; S Souquières; F Simon
Journal:  Emerg Infect Dis       Date:  2001 May-Jun       Impact factor: 6.883

10.  Reconstitution of an infectious human endogenous retrovirus.

Authors:  Young Nam Lee; Paul D Bieniasz
Journal:  PLoS Pathog       Date:  2007-01       Impact factor: 6.823

View more
  37 in total

1.  The ability of primate lentiviruses to degrade the monocyte restriction factor SAMHD1 preceded the birth of the viral accessory protein Vpx.

Authors:  Efrem S Lim; Oliver I Fregoso; Connor O McCoy; Frederick A Matsen; Harmit S Malik; Michael Emerman
Journal:  Cell Host Microbe       Date:  2012-01-26       Impact factor: 21.023

Review 2.  HIV-1 reverse transcription.

Authors:  Wei-Shau Hu; Stephen H Hughes
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

3.  A glycan shield on chimpanzee CD4 protects against infection by primate lentiviruses (HIV/SIV).

Authors:  Cody J Warren; Nicholas R Meyerson; Alex C Stabell; Will T Fattor; Gregory K Wilkerson; Sara L Sawyer
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-21       Impact factor: 11.205

4.  Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.

Authors:  Zeli Zhang; Qinyong Gu; Ananda Ayyappan Jaguva Vasudevan; Manimehalai Jeyaraj; Stanislaw Schmidt; Jörg Zielonka; Mario Perković; Jens-Ove Heckel; Klaus Cichutek; Dieter Häussinger; Sander H J Smits; Carsten Münk
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

5.  Origin and biology of simian immunodeficiency virus in wild-living western gorillas.

Authors:  Jun Takehisa; Matthias H Kraus; Ahidjo Ayouba; Elizabeth Bailes; Fran Van Heuverswyn; Julie M Decker; Yingying Li; Rebecca S Rudicell; Gerald H Learn; Cecile Neel; Eitel Mpoudi Ngole; George M Shaw; Martine Peeters; Paul M Sharp; Beatrice H Hahn
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

6.  A rev1-vpu polymorphism unique to HIV-1 subtype A and C strains impairs envelope glycoprotein expression from rev-vpu-env cassettes and reduces virion infectivity in pseudotyping assays.

Authors:  Matthias H Kraus; Nicholas F Parrish; Katharina S Shaw; Julie M Decker; Brandon F Keele; Jesus F Salazar-Gonzalez; Truman Grayson; David T McPherson; Li-Hua Ping; Jeffrey A Anderson; Ronald Swanstrom; Carolyn Williamson; George M Shaw; Beatrice H Hahn
Journal:  Virology       Date:  2009-12-08       Impact factor: 3.616

7.  Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses.

Authors:  Jan Münch; Devi Rajan; Michael Schindler; Anke Specht; Elke Rücker; Francis J Novembre; Eric Nerrienet; Michaela C Müller-Trutwin; Martine Peeters; Beatrice H Hahn; Frank Kirchhoff
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

Review 8.  Putting synthesis into biology: a viral view of genetic engineering through de novo gene and genome synthesis.

Authors:  Steffen Mueller; J Robert Coleman; Eckard Wimmer
Journal:  Chem Biol       Date:  2009-03-27

Review 9.  Synthetic viruses: a new opportunity to understand and prevent viral disease.

Authors:  Eckard Wimmer; Steffen Mueller; Terrence M Tumpey; Jeffery K Taubenberger
Journal:  Nat Biotechnol       Date:  2009-12       Impact factor: 54.908

10.  The y271 and i274 amino acids in reverse transcriptase of human immunodeficiency virus-1 are critical to protein stability.

Authors:  Hao-Jie Zhang; Yong-Xiang Wang; Hao Wu; Dong-Yan Jin; Yu-Mei Wen; Bo-Jian Zheng
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.